Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta ‐blocker use: a Danish nationwide cohort study

ConclusionCarvedilol prescription carried an increased hazard of HF hospitalization and lower restricted mean persistence time among patients with COPD and concurrent HF. Additionally, we found a widespread phenomenon of carvedilol prescription at variance with the European Society of Cardiology guidelines and potential for improving the proportion of patients treated with β‐blockers.

Source: European Journal of Heart Failure - November 1, 2017 Category: Cardiology Authors: Maurizio Sessa, Annamaria Mascolo, Rikke N ørmark Mortensen, Mikkel Porsborg Andersen, Giuseppe Massimo Claudio Rosano, Annalisa Capuano, Francesco Rossi, Gunnar Gislason, Henrik Enghusen‐Poulsen, Christian Torp‐Pedersen Tags: Research Article Source Type: research